Norepinephrine in Preperiod of Hypotensive Resuscitation in Hemorrhagic Shock

Launched by TANTA UNIVERSITY · Mar 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a medication called norepinephrine on patients who are experiencing a serious condition known as hemorrhagic shock, which occurs when someone loses a lot of blood. The researchers want to see if giving a low dose of norepinephrine before starting treatment to stabilize blood pressure can help improve outcomes for these patients.

To participate in this trial, individuals must be at least 18 years old and experiencing hemorrhagic shock. However, those who have suffered cardiac arrest, severe brain or spinal injuries, or are pregnant cannot join. If eligible, participants will receive norepinephrine during their treatment and will be monitored closely by the medical team. This study aims to find safer and more effective ways to manage patients in critical condition, ultimately helping improve their chances of recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years old.
• • Both sexes.
• • Patients with hemorrhagic shock
• Exclusion Criteria:
• • Patients with cardiac arrest at admission.
• • Severe brain.
• • Spinal injury (because of different target blood pressures).
• • Death due to hemostatic failure within 6 h of admission.
• • Pregnancy.